- Home
- PODD vs MKL Comparison
PODD vs MKL Comparison
Compare PODD & MKL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PODD
- MKL
- Stock Information
- Founded
- PODD 2000
- MKL 1930
- Country
- PODD United States
- MKL United States
- Employees
- PODD N/A
- MKL N/A
- Industry
- PODD Medical/Dental Instruments
- MKL Property-Casualty Insurers
- Sector
- PODD Health Care
- MKL Finance
- Exchange
- PODD Nasdaq
- MKL Nasdaq
- Market Cap
- PODD 22.1B
- MKL 24.4B
- IPO Year
- PODD 2007
- MKL 1986
- Fundamental
- Price
- PODD $320.10
- MKL $2,035.00
- Analyst Decision
- PODD Strong Buy
- MKL Hold
- Analyst Count
- PODD 19
- MKL 2
- Target Price
- PODD $346.95
- MKL $1,930.50
- AVG Volume (30 Days)
- PODD 532.2K
- MKL 43.2K
- Earning Date
- PODD 11-06-2025
- MKL 10-29-2025
- Dividend Yield
- PODD N/A
- MKL N/A
- EPS Growth
- PODD N/A
- MKL N/A
- EPS
- PODD 3.45
- MKL 142.27
- Revenue
- PODD $2,521,800,000.00
- MKL $16,210,307,000.00
- Revenue This Year
- PODD $29.32
- MKL N/A
- Revenue Next Year
- PODD $18.37
- MKL $0.39
- P/E Ratio
- PODD $92.68
- MKL $14.32
- Revenue Growth
- PODD 27.11
- MKL N/A
- 52 Week Low
- PODD $230.05
- MKL $1,620.61
- 52 Week High
- PODD $353.50
- MKL $2,075.92
- Technical
- Relative Strength Index (RSI)
- PODD 50.14
- MKL 65.93
- Support Level
- PODD $290.16
- MKL $1,943.75
- Resistance Level
- PODD $335.00
- MKL $1,976.79
- Average True Range (ATR)
- PODD 10.46
- MKL 34.68
- MACD
- PODD 0.04
- MKL 16.64
- Stochastic Oscillator
- PODD 66.39
- MKL 99.22
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.
About MKL Markel Group Inc.
Markel's primary business is property and casualty insurance. The company focuses primarily on specialty lines, ranging from areas such as executive liability to commercial equine insurance. The acquisition of Alterra in 2013 added substantial reinsurance operations, which now account for a little over 10% of premiums. The company uses capital generated by its insurance operations to buy noninsurance operations in diverse areas, such as bakery equipment manufacturing and residential homebuilding.